A breast cancer diagnosis changes everything in an instant. The flood of medical terms, the treatment options, and the decisions to make can feel overwhelming. This guide is here to help you understand what you're facing, what your options are, and how to find the right care, wherever you are in the world.
Understanding Breast Cancer: The Basics
Breast cancer is not one disease, it is a family of diseases. Your treatment plan should be as unique as your diagnosis. The main types include:
- Ductal Carcinoma In Situ (DCIS): Non-invasive, confined to milk ducts, highly treatable
- Invasive Ductal Carcinoma (IDC): Most common type, spreads beyond duct walls into breast tissue
- Invasive Lobular Carcinoma (ILC): Starts in milk-producing glands, can be harder to detect on mammograms
- Triple-Negative Breast Cancer: Lacks estrogen, progesterone, and HER2 receptors, so it often requires chemotherapy-based approaches
- HER2-Positive Breast Cancer: Overexpresses HER2 protein; responds well to targeted therapies like trastuzumab
- Hormone Receptor-Positive (HR+): Driven by estrogen/progesterone; hormonal therapy is a key component
The Diagnostic Journey: What to Expect
Accurate diagnosis is the foundation of effective treatment. Modern breast cancer diagnosis goes beyond a simple biopsy.
- Imaging: Mammography, ultrasound, and MRI to visualize the tumour
- Biopsy and Pathology: Core needle or surgical biopsy to confirm cancer type and grade
- Molecular Profiling: Tests like Oncotype DX or MammaPrint determine recurrence risk and chemo necessity
- Staging: CT, PET, or bone scans to assess spread (Stage I-IV)
- Genetic Testing: BRCA1/BRCA2 testing for hereditary risk assessment
Treatment Options: What Modern Oncology Offers
Treatment is rarely one-size-fits-all. Most patients receive a combination of therapies, sequenced based on their specific cancer biology.
- Surgery: Lumpectomy (breast-conserving) or mastectomy; reconstructive options available
- Radiation Therapy: After surgery to eliminate remaining cells; IMRT and proton therapy reduce side effects
- Chemotherapy: Systemic treatment, may be given before surgery (neoadjuvant) or after (adjuvant)
- Targeted Therapy: HER2-directed drugs (trastuzumab, pertuzumab, T-DM1) for HER2+ cancers
- Hormonal Therapy: Tamoxifen, aromatase inhibitors for HR+ cancers, often for 5-10 years
- Immunotherapy: Pembrolizumab for triple-negative breast cancer in eligible patients
- CDK4/6 Inhibitors: Palbociclib, ribociclib for metastatic HR+ disease
Why India for Breast Cancer Treatment?
India's top cancer centres offer the same evidence-based protocols used at leading institutions in the US, UK, and Europe, often at 60-80% lower cost. Benefits include:
- JCI-accredited hospitals with dedicated breast oncology teams
- Access to oncoplastic surgeons for breast-conserving procedures with cosmetic outcomes
- Molecular tumour boards that review complex cases collaboratively
- Shorter wait times compared to many Western healthcare systems
- Integrated support: dietitians, psycho-oncologists, and physiotherapists
How eCureTrip Supports Your Journey
eCureTrip is a specialist medical facilitation platform for international cancer patients. We go beyond logistics to provide clinical partnership:
- eCureMap: Your personalised care roadmap, from diagnosis to survivorship
- Virtual Tumor Board: Multi-specialist review of your case before you travel
- Transparent Costing: Line-item cost estimates with no hidden fees
- Second Opinion Service: Independent review of your diagnosis and treatment plan
- End-to-End Support: Visa, travel, accommodation, and in-hospital coordination
Ready to take the next step? Share your reports and we'll help you find the right care.
Start your journey